Gout and diabetes: a common combination.
Andrew Collier1, Angus Stirling1, Lyall Cameron2
1Diabetes Day Centre, Ayr Hospital, Ayr, UK.
Postgraduate Medical Journal
|May 12, 2016
Summary
People with gout and type 2 diabetes (T2DM) share metabolic and lifestyle factors. Better glycemic control and not smoking are linked to higher gout prevalence in T2DM patients.
Area of Science:
- Metabolic health
- Endocrinology
- Rheumatology
Background:
- Gout and type 2 diabetes mellitus (T2DM) are common, chronic conditions.
- Understanding the overlap and shared characteristics is crucial for patient management.
Purpose of the Study:
- To compare metabolic parameters in patients with gout and T2DM, gout only, and T2DM only.
- To investigate the prevalence and associations of gout in a T2DM population.
Main Methods:
- Cross-sectional study analyzing data from 50 General Practices.
- Categorized patients into three groups: gout with T2DM, gout only, and T2DM only.
- Compared demographic, metabolic, and clinical characteristics across groups.
Main Results:
- Prevalence of gout in T2DM patients was 10.12% compared to 1.90% in type 1 diabetes.
- Patients with both gout and T2DM were more likely to be male, older, have higher BMI, triglycerides, lower cholesterol, reduced kidney function, and higher medication use.
- Lower hemoglobin A1c and lower smoking rates were associated with increased gout prevalence.
Conclusions:
- Gout and T2DM frequently coexist and share significant metabolic and demographic risk factors.
- Lifestyle factors like glycemic control and smoking status are associated with gout prevalence in T2DM patients.
More Related Videos
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
804
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
14.2K
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
5.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.4K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.9K
01:20Pathophysiology of Diabetes
4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.7K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.7K
01:23Dipeptidyl Peptidase 4 Inhibitors
982
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
982
01:15Diabetes: Management and Pharmacotherapy
1.4K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.4K